1 Center for Respiratory and Pulmonary Vascular Disease, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Department of Cardiology, Fuwai ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on developing innovative therapies for unmet needs, today announced that the U.S. Food and Drug Administration (FDA) has ...

If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this disorder can develop without noticeable symptoms, making it hard to catch.

Researchers identified two genes — PRDX1 and TNFAIP3 — whose activity levels could serve as diagnostic biomarkers for idiopathic pulmonary arterial hypertension (PAH). The genes are related to ...

The use of GLP-1 RAs was associated with lower medication use, reduced headaches, visual disturbances or blindness, and papilledema. HealthDay News — For patients with idiopathic intracranial ...

Incidence rates for depression and anxiety has not been previously evaluated in a large matched cohort study in idiopathic intracranial hypertension (IIH). We analysed data collected between ...

Background Idiopathic intracranial hypertension (IIH) is a complex neurological condition characterized by symptoms of increased intracranial pressure of unclear etiology. While transverse sinus ...

Abstract DP36: Efficacy of Endovascular Treatment for Idiopathic Intracranial Hypertension：Cerebral Venous Sinus Stenosis Treated by Stenting Jian Chen, BS, PhD, Di Wu, PhD, and Xunming Ji, MD Author ...

Idiopathic intracranial hypertension affects 3.44 per 10,000 US women aged 18 to 55. Among women in the US, the prevalence of idiopathic intracranial hypertension varied geographically, which is ...